BRAF c.308T>A ;(p.L103Q)

Variant ID: 7-140534605-A-T

NM_004333.4(BRAF):c.308T>A;(p.L103Q)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.

Blood Advances
Chihara, Dai D; Arons, Evgeny E; Stetler-Stevenson, Maryalice M; Yuan, Constance C; Wang, Hao-Wei HW; Zhou, Hong H; Raffeld, Mark M; Xi, Liqiang L; Steinberg, Seth M SM; Feurtado, Julie J; James-Echenique, Lacey L; Tai, Chin-Hsien CH; Patel, Keyur P KP; Braylan, Raul C RC; Calvo, Katherine R KR; Maric, Irina I; Dulau-Florea, Alina A; Kreitman, Robert J RJ
Publication Date: 2021-12-14

Variant appearance in text: BRAF: 308T>A
PubMed Link: 34607348
Variant Present in the following documents:
  • Main text
View BVdb publication page